Search

Alvydas J Ozinskas

age ~67

from Brookeville, MD

Also known as:
  • Alvydas Ozinskas
  • Alvydas R
  • Alvydas S
  • S S

Alvydas Ozinskas Phones & Addresses

  • Brookeville, MD
  • 5002 Centaurus Ct, Dayton, MD 21036 • (410)5313448
  • Chalfont, PA
  • Ashton, MD
  • 5002 Centaurus Ct, Dayton, MD 21036 • (410)8088932

Work

  • Position:
    Professional/Technical

Education

  • Degree:
    Graduate or professional degree

Emails

Us Patents

  • Detection Of Multiple Analytes From A Single Sample Using A Multi-Well, Multi-Analyte Flow-Through Diagnostic Test Device

    view source
  • US Patent:
    7052831, May 30, 2006
  • Filed:
    Dec 8, 2000
  • Appl. No.:
    09/732838
  • Inventors:
    Robert C. Fletcher - Phoenixville PA,
    Alvydas J. Ozinskas - Dayton MD,
    Kenneth Kopher - Baltimore MD,
    John Gill - Phoenix MD,
  • Assignee:
    Becton Dickinson and Company - Franklin Lakes NJ
  • International Classification:
    C12Q 1/70
  • US Classification:
    435 5, 422 56, 422 57, 422 58, 422 61, 435 79, 435 792, 4352871, 4352872, 435973, 435975, 436518, 436809
  • Abstract:
    The present invention provides a method and device for conducting a rapid in vitro enzyme immunoassay test for the direct and qualitative detection of two or more viral antigens from specimens of symptomatic patients. The method for immunoassay of viral antigens is performed on a membrane. Non-immunological capture of viral antigens takes place by absorption onto the membrane. Captured antigen binds to a detection reagent that includes a label conjugated to a specific antibody. The test is a differentiated test such that two or more viral antigens may be distinguished from each other in a single test. The invention also includes a kit for performing an assay in accordance with the method of the present invention, wherein the kit comprises the device of the present invention.
  • Assay Of Blood Or Other Biologic Samples For Target Analytes

    view source
  • US Patent:
    5635362, Jun 3, 1997
  • Filed:
    May 23, 1994
  • Appl. No.:
    8/247336
  • Inventors:
    Robert A. Levine - Guilford CT
    Stephen C. Wardlaw - Old Saybrook CT
    Rodolfo R. Rodriguez - Owings Mills MD
    Adrien P. Malick - Granite MD
    Alvydas J. Ozinskas - Dayton MD
  • Assignee:
    Becton Dickinson and Co. - Franklin Lakes NJ
  • International Classification:
    G01N 33543
    G01N 33558
  • US Classification:
    435 724
  • Abstract:
    A patient's health may be diagnosed by centrifuging blood samples in a transparent tube, which tube contains one or more bodies or groups of bodies such as floats, inserts, liposomes, or plastic beads of different densities. Each density-defined body carries analyte-capture binding materials such as antigens or antibodies, which are specific to an epitope, or other specific high affinity binding site on a target analyte which target analyte may be in the blood or other sample being tested; and the level of which analyte is indicative of the patient's health. At least one labeled binding material which is also specific to an epitope, or other specific high affinity binding site on the target analyte is added to the sample so as to form labeled binding material/analyte/body complexes in the sample. Upon centrifugation, the complexes will settle out in different areas in the tube according to the respective density of the body or bodies; and the degree of label emission of the complex layers can enable qualitative and/or quantitative analyses of the sample to be made. Unbound labeled binding materials will be separated from the complexed layers by the washing action of ascending or descending components of the sample during the centrifugation step.
  • Assay Of Blood Or Other Biologic Samples For Target Analytes

    view source
  • US Patent:
    5834217, Nov 10, 1998
  • Filed:
    Dec 11, 1996
  • Appl. No.:
    8/763858
  • Inventors:
    Robert A. Levine - Guilford CT
    Stephen C. Wardlaw - Old Saybrook CT
    Leon W. M. M. Terstappen - Palo Alto CA
    Kristen L. Manion - Benecia CA
    Rodolfo R. Rodriguez - Owings Mills MD
    Adrien P. Malick - Granite MD
    Subhash Dhanesar - Owings Mills MD
    Stephen J. Lovell - Baltimore MD
    Alvydas J. Ozinskas - Dayton MD
  • Assignee:
    Becton Dickinson and Co. - Franklin Lakes NJ
  • International Classification:
    G01N 33543
    G01N 33546
  • US Classification:
    435 724
  • Abstract:
    A patient's health may be diagnosed by centrifuging blood samples in a transparent tube, which tube contains one or more bodies or groups of bodies such as floats, inserts, liposomes, or plastic beads of different densities. Each density-defined body carries analyte-capture binding materials such as antigens or antibodies, which are specific to an epitope, or other specific high affinity binding site on a target analyte which target analyte may be in the blood or other sample being tested; and the level of which analyte is indicative of the patient's health. At least one labeled binding material which is also specific to an epitope, or other specific high affinity binding site on the target analyte is added to the sample so as to form labeled binding material/analyte/body complexes in the sample. Upon centrifugation, the complexes will settle out in different areas in the tube according to the respective density of the body or bodies; and the degree of label emission of the complex layers can enable qualitative and/or quantitative analyses of the sample to be made. Unbound labeled binding materials will be separated from the complexed layers by the washing action of ascending or descending components of the sample during the centrifugation step.
  • Assay Of Blood Or Other Biologic Samples For Target Analytes

    view source
  • US Patent:
    5776710, Jul 7, 1998
  • Filed:
    Dec 23, 1996
  • Appl. No.:
    8/771507
  • Inventors:
    Robert A. Levine - Guilford CT
    Stephen C. Wardlaw - Old Saybrook CT
    Leon W. M. M. Terstappen - Palo Alto CA
    Kristen L. Manion - Benecia CA
    Rodolfo R. Rodriguez - Owings Mills MD
    Adrien P. Malick - Granite MD
    Subhash Dhanesar - Owings Mills MD
    Stephen J. Lovell - Baltimore MD
    Alvydas J. Ozinskas - Dayton MD
  • Assignee:
    Becton Dickinson and Co. - Franklin Lakes NJ
  • International Classification:
    G01N 33543
    G01N 33558
  • US Classification:
    435 724
  • Abstract:
    A patient's health may be diagnosed by centrifuging blood samples in a transparent tube, which tube contains one or more bodies or groups of bodies such as floats, inserts, liposomes, or plastic beads of different densities. Each density-defined body carries analyte-capture binding materials such as antigens or antibodies, which are specific to an epitope, or other specific high affinity binding site on a target analyte which target analyte may be in the blood or other sample being tested; and the level of which analyte is indicative of the patient's health. At least one labeled binding material which is also specific to an epitope, or other specific high affinity binding site on the target analyte is added to the sample so as to form labeled binding material/analyte/body complexes in the sample. Upon centrifugation, the complexes will settle out in different areas in the tube according to the respective density of the body or bodies; and the degree of label emission of the complex layers can enable qualitative and/or quantitative analyses of the sample to be made. Unbound labeled binding materials will be separated from the complexed layers by the washing action of ascending or descending components of the sample during the centrifugation step.
  • Fluorescent Energy Transfer Immunoassay

    view source
  • US Patent:
    5631169, May 20, 1997
  • Filed:
    Jan 19, 1994
  • Appl. No.:
    8/183238
  • Inventors:
    Joseph R. Lakowicz - Columbia MD
    Badri P. Maliwal - Baltimore MD
    Richard Thompson - Baltimore MD
    Alvydas Ozinskas - Dayton MD
  • International Classification:
    G01N 33533
  • US Classification:
    436537
  • Abstract:
    A fluorometric luminescence immunoassay method includes forming a sample by exposing a first immune reaction reactant to a second immune reaction reactant capable of reacting with the first reactant, one of the first and second immune reaction reactants being labelled with a photoluminescent energy transfer donor and the other being labelled with a photoluminescent energy transfer acceptor complementary to the photoluminescent donor. At least the photoluminescent donor has the property of photoluminescence, and the photoluminescent donor and acceptor are chosen so that when the first immune reaction reactant reacts with the second immune reaction reactant, the donor and the acceptor are capable of interacting to produce a detectable luminescence lifetime change. The sample is excited with radiation, and the resulting emission is detected. The apparent luminescent lifetime is then calculated to determine the presence of a reaction product of the first and second immune reaction reactants.
Name / Title
Company / Classification
Phones & Addresses
Alvydas Ozinskas
Owner
M Melinda Thompson
General Practice Attorney Lawyer
4994 Centaurus Ct, Dayton, MD 21036

Resumes

Alvydas Ozinskas Photo 1

Alvydas Ozinskas

view source

Facebook

Alvydas Ozinskas Photo 2

Alvydas Ozinskas

view source

Get Report for Alvydas J Ozinskas from Brookeville, MD, age ~67
Control profile